N@N

David Nierengarten Downgraded (TSVT) to Hold and Held Target at $2 on, Nov 20th, 2023

David Nierengarten of Wedbush, Downgraded "2seventy bio, Inc." (TSVT) to Hold and Held Target at $2 on, Nov 20th, 2023.

David has made no other calls on TSVT in the last 4 months.

There are 5 other peers that have a rating on TSVT. Out of the 5 peers that are also analyzing TSVT, 4 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Daina Graybosch of "Leerink Partners" Downgraded from Buy to Hold on, Monday, October 30th, 2023
• Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Held Target at $5 on, Wednesday, September 13th, 2023
• Kelsey Goodwin of "Guggenheim" Downgraded from Strong Buy to Hold on, Wednesday, September 13th, 2023
• Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $13 on, Friday, July 28th, 2023

This is the rating of the analyst that currently disagrees with David

---

• Samantha Semenkow of "Citigroup" Initiated at Strong Buy and Held Target at $13 on, Thursday, October 12th, 2023

Contributing Sources

---